Generalized Social Anxiety Disorder (SAD) is one of the most common anxiety disorders. This mood disorder SAD should not confused with the other mood disorder SAD, meaning seasonal affective disorder–a type of depression.
The conventional pharmaceutical treatment of SAD has proven to have low efficacy rates, meaning it is poorly controlled by the available drugs. Only 30% of SAD patients achieve remission. It is clear to the patients and medical community new treatments are necessary for treating SAD.
Here is the full scientific article if you wish to download it.
Some novel therapies, however, have showed promise. Both animal and human studies indicate that cannabidiol (CBD), a major constituent of cannabis, has anxiolytic properties. Anxiolytic means anti-anxiety. CBD is a chemical compound called a cannabinoid. CBD, unlike it’s fellow cannabinoid Δ⁹-tetrahydrocannabinol (THC), is non-psychoactive. This means it does not give the user a “high,” as is often associated with cannabis.
Given CBD’s low toxicity, minimal adverse side effects and excellent safety profile, and medicinal benefits, it has proven very promising in medical studies. No prior study had investigated the effects of this compound on human pathological anxiety and its underlying brain mechanisms. The aim of the below study was to investigate this in patients with generalized social anxiety disorder.
This did so using functional neuroimaging. In the second session, the same procedure was performed using the drug that had not been administered in the previous session. Within-subject between-condition rCBF comparisons were performed using statistical parametric mapping.
The results were promising. Relative to placebo, CBD was associated with significantly decreased subjective anxiety, reduced ECD uptake in the left parahippocampal gyrus, hippocampus, and inferior temporal gyrus, and increased ECD uptake in the right posterior cingulate gyrus. These results suggest that CBD reduces anxiety in SAD, and that this is shown by its effects on activity in limbic and paralimbic brain areas.
If you’re interested in using CBD, you should first consult your doctor or a medical professional. They’re best qualified to suggest treatment plans. CBD, when derived from hemp, is negligible in THC content, meaning less than .3%. As a result, it is less often outlawed than general marijuana and products with THC.
You should also consult your local laws to assure you are not partaking in illegal activity. CBD can come as an isolate or full-spectrum. Full-spectrum contains THC and, is therefore, not legal in states with legalized medical cannabis.